Cellivate Technologies Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1M

  • Investors
  • 12

Cellivate Technologies General Information

Description

Provider of a cell-culture supplement intended for reducing reliance on animal-derived inputs in research and production processes. The company's platform incorporates extracellular-vesicle-based components, xeno-free formulations, and controlled manufacturing practices, enabling pharmaceutical, biotechnology, skincare, and cultivated-materials markets to maintain cell growth consistency, limit batch variability, support regulatory alignment, and decrease dependence on conventional serum-based materials.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 160 Robinson Road
  • Number 14-04
  • Singapore, 068914
  • Singapore
+65 8782
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 160 Robinson Road
  • Number 14-04
  • Singapore, 068914
  • Singapore
+65 8782

Cellivate Technologies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellivate Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 06-Aug-2024 $1M Completed Generating Revenue
4. Seed Round 04-Jan-2024 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator 14-Mar-2022 Completed Generating Revenue
To view Cellivate Technologies’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cellivate Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellivate Technologies Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hatcher+ Venture Capital Minority
Inflection Point Ventures (India) Angel Group Minority
Venture Catalysts Accelerator/Incubator Minority
Venture Catalysts (Private Equity) VC-Backed Company Minority
We Founder Circle Angel Group Minority
You’re viewing 5 of 12 investors. Get the full list »

Cellivate Technologies FAQs

  • When was Cellivate Technologies founded?

    Cellivate Technologies was founded in 2019.

  • Where is Cellivate Technologies headquartered?

    Cellivate Technologies is headquartered in Singapore, Singapore.

  • What is the size of Cellivate Technologies?

    Cellivate Technologies has 6 total employees.

  • What industry is Cellivate Technologies in?

    Cellivate Technologies’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Cellivate Technologies a private or public company?

    Cellivate Technologies is a Private company.

  • What is Cellivate Technologies’s current revenue?

    The current revenue for Cellivate Technologies is .

  • How much funding has Cellivate Technologies raised over time?

    Cellivate Technologies has raised $4.12M.

  • Who are Cellivate Technologies’s investors?

    Hatcher+, Inflection Point Ventures (India), Venture Catalysts, Venture Catalysts (Private Equity), and We Founder Circle are 5 of 12 investors who have invested in Cellivate Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process